Drug
Difluprednate Ophthalmic Emulsion
Difluprednate Ophthalmic Emulsion is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 6 completed trials
Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
3
50%
Ph phase_2
3
50%
Phase Distribution
0
Early Stage
3
Mid Stage
3
Late Stage
Phase Distribution6 total trials
Phase 2Efficacy & side effects
3(50.0%)
Phase 3Large-scale testing
3(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
6 of 6 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(6)
Detailed Status
Completed6
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 23 (50.0%)
Phase 33 (50.0%)
Trials by Status
completed6100%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_2
Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation
NCT00407225
completedphase_3
Study of Difluprednate Ophthalmic Emulsion in Postoperative Inflammation
NCT00406341
completedphase_3
Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis
NCT00406887
completedphase_3
Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis
NCT00407056
completedphase_2
Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation
NCT00406497
Clinical Trials (6)
Showing 6 of 6 trials
NCT00407225Phase 2
Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation
NCT00406341Phase 3
Study of Difluprednate Ophthalmic Emulsion in Postoperative Inflammation
NCT00406887Phase 3
Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis
NCT00407056Phase 3
Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis
NCT00406497Phase 2
Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation
NCT00405496Phase 2
Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6